The value of novel biomarker BDNF in early diagnosis and prognosis evaluation of coronary atherosclerotic calcification plaque

The value of novel biomarker BDNF in early diagnosis and prognosis evaluation of coronary atherosclerotic calcification plaque

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800020259

Enrollment

Unknown

Registered

2018-12-21

Start date

2019-01-01

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerosis

Interventions

Clinical classification, GRACE risk stratification, number of diseased vessels, and Gensini coronary artery scoring system:Nil

Sponsors

Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University

Lead Sponsor

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Due to acute chest pain or acute coronary syndrome, the Department of Cardiology, the affiliated hospital of Southeast University, concurrently with coronary CT examination

Exclusion criteria

Exclusion criteria: Severe heart valve disease, coronary artery bypass grafting, cardiomyopathy, tumor or pregnancy

Design outcomes

Primary

Measure	Time frame
Brain Derived Neurotrophic Factor;	—

Countries

china

Contacts

Public ContactHong Jin

Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University

13851925985@163.com+86 13851925985

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026